Albaracin, Richard R.

HRN: 26-02-35  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/15/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/15/2024
10/22/2024
IV
500mg
Q8
UTI, Ascariasis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: